Our Services
Medical Information
Helpful Resources
Published on: 9/14/2026
Yes, untreated insulin resistance can lead to lasting damage to both the heart and kidneys, because chronically high insulin and blood sugar levels quietly injure blood vessels, raise blood pressure, and strain the kidneys' filtering units years before diabetes is diagnosed. Early damage such as mild protein in the urine, thickened heart muscle, or arterial plaque may be partly reversible with weight loss, exercise, and medication, while advanced scarring and chronic kidney disease generally are not. Your personal risk depends on how long the condition has gone unaddressed, your blood pressure, cholesterol, family history, and whether you already show early warning signs. There are several important factors and specific symptoms to consider, so see below to understand more before assuming your situation is harmless.
If you are unsure whether your symptoms point to insulin resistance or to early heart or kidney involvement, guessing wastes the window when damage is still reversible, and a free, instant, online symptom check can help you organize what you are experiencing and decide how urgently to see a doctor.
Last reviewed for medical accuracy: 09/13/2026
Insulin Resistance: Can Ignoring It Permanently Damage Your Heart or Kidneys?
Insulin resistance occurs when your body’s cells stop responding properly to insulin, the hormone that helps move glucose from your bloodstream into cells for energy. Over time, this condition can lead to higher blood sugar levels, setting the stage for type 2 diabetes and affecting multiple organs—including your heart and kidneys.
What Is Insulin Resistance?
Insulin resistance isn’t a disease itself but a warning sign that your metabolism is under stress. Common factors include:
Early on, your pancreas compensates by producing more insulin. But with persistent resistance, insulin production can’t keep up, and blood sugar levels start to climb.
How Insulin Resistance Harms Your Body
High circulating glucose and insulin levels—often for years before a diabetes diagnosis—can damage blood vessels, nerves and tissues. Two critical targets are:
Understanding how this damage happens can motivate timely action.
Impact on Your Heart
The American Heart Association recognizes insulin resistance as a major risk factor for cardiovascular disease. Here’s how it contributes:
Left unchecked, these processes can lead to coronary artery disease, heart failure or even sudden cardiac events.
Impact on Your Kidneys
According to the National Kidney Foundation, insulin resistance and high blood sugar exert several stresses on your kidneys:
If allowed to progress, these changes can culminate in chronic kidney disease (CKD) or end-stage renal disease (ESRD), requiring dialysis or transplant.
Can This Damage Be Reversed?
Early intervention can halt or even reverse some effects of insulin resistance:
Studies in diabetes prevention programs and clinical trials (e.g., the Diabetes Prevention Program Research Group) show that modest weight loss (5–7%) and 150 minutes of weekly moderate exercise can cut progression to diabetes by up to 58%. Better glucose control also limits damaging glucose spikes that injure vessels and filtering units.
However, once structural damage—such as significant arterial plaque or advanced scarring in the kidneys—has occurred, it’s often irreversible. While treatments can slow future decline, restoring full organ function may not be possible.
Signs You Shouldn’t Ignore
Watch for symptoms that suggest your heart or kidneys are under strain:
Heart-Related
Kidney-Related
If you notice any of these signs—or if you have risk factors like high blood sugar, high blood pressure or a family history of heart or kidney disease—consider a free, online symptom check, using the doctor approved Ubie Symptom Checker to help you decide if you need urgent care.
Preventing Permanent Damage
The good news is that you have considerable control over how insulin resistance unfolds. Key steps include:
Adopting a Balanced Diet
Increasing Physical Activity
Managing Weight
Monitoring Health Metrics
Medication Adherence
Stress and Sleep Management
Speak to a Doctor About Anything Serious
No amount of online research or symptom-checking can fully replace personalized medical advice. If you experience any alarming symptoms or if you’re concerned about heart or kidney health, please speak to a qualified healthcare professional promptly. Early evaluation and treatment are crucial to prevent irreversible damage.
Bottom Line
Insulin resistance is a signal that your metabolism is out of balance. If left unchecked, it can lead to permanent damage in critical organs like the heart and kidneys. The earlier you act—with lifestyle changes, medical management and regular monitoring—the better your chances of reversing or slowing disease progression. Use tools like the doctor approved Ubie Symptom Checker for a quick, free, online symptom check, and always follow up with your doctor for personalized care. Take charge of insulin resistance now to protect your heart, kidneys and overall health for years to come.
(References)
* Ndumele CE, Neeland IJ, Tuttle KR, Chow SL, Mathew RO, Khan SS, Coresh J, Baker-Smith CM, Carnethon MR, Després JP, Ho JE, Joseph JJ, Kernan WN, Khera A, Kosiborod MN, Lekavich CL, Lewis EF, Lo KB, Ozkan B, Palaniappan LP, Patel SS, Pencina MJ, Powell-Wiley TM, Sperling LS, Virani SS, Wright JT, Rajgopal Singh R, Elkind MSV, Rangaswami J, American Heart Association. A Synopsis of the Evidence for the Science and Clinical Management of Cardiovascular-Kidney-Metabolic (CKM) Syndrome: A Scientific Statement From the American Heart Association. Circulation. 2023 Nov 14;148(20):1636-1664. doi: 10.1161/CIR.0000000000001186. Epub 2023 Oct 9. PMID: 37807920.
* Sebastian SA, Padda I, Johal G. Cardiovascular-Kidney-Metabolic (CKM) syndrome: A state-of-the-art review. Curr Probl Cardiol. 2024 Feb;49(2):102344. doi: 10.1016/j.cpcardiol.2023.102344. Epub 2023 Dec 14. PMID: 38103820.
* Li W, Shen C, Kong W, Zhou X, Fan H, Zhang Y, Liu Z, Zheng L. Association between the triglyceride glucose-body mass index and future cardiovascular disease risk in a population with Cardiovascular-Kidney-Metabolic syndrome stage 0-3: a nationwide prospective cohort study. Cardiovasc Diabetol. 2024 Aug 7;23(1):292. doi: 10.1186/s12933-024-02352-6. Epub 2024 Aug 7. PMID: 39113004; PMCID: PMC11308445.
* Kittelson KS, Junior AG, Fillmore N, da Silva Gomes R. Cardiovascular-kidney-metabolic syndrome - An integrative review. Prog Cardiovasc Dis. 2024 Nov-Dec;87:26-36. doi: 10.1016/j.pcad.2024.10.012. Epub 2024 Oct 30. PMID: 39486671; PMCID: PMC11619311.
* Ferdinand KC. An overview of cardiovascular-kidney-metabolic syndrome. Am J Manag Care. 2024 Dec;30(10 Suppl):S181-S188. doi: 10.37765/ajmc.2024.89670. PMID: 39705194.
* Theodorakis N, Nikolaou M. From Cardiovascular-Kidney-Metabolic Syndrome to Cardiovascular-Renal-Hepatic-Metabolic Syndrome: Proposing an Expanded Framework. Biomolecules. 2025 Feb 2;15(2). doi: 10.3390/biom15020213. Epub 2025 Feb 2. PMID: 40001516; PMCID: PMC11853431.
* Tan MY, Zhang YJ, Zhu SX, Wu S, Zhang P, Gao M. The prognostic significance of stress hyperglycemia ratio in evaluating all-cause and cardiovascular mortality risk among individuals across stages 0-3 of cardiovascular-kidney-metabolic syndrome: evidence from two cohort studies. Cardiovasc Diabetol. 2025 Mar 24;24(1):137. doi: 10.1186/s12933-025-02689-6. Epub 2025 Mar 24. PMID: 40128747; PMCID: PMC11934678.
* Dong B, Chen Y, Yang X, Chen Z, Zhang H, Gao Y, Zhao E, Zhang C. Estimated glucose disposal rate outperforms other insulin resistance surrogates in predicting incident cardiovascular diseases in cardiovascular-kidney-metabolic syndrome stages 0-3 and the development of a machine learning prediction model: a nationwide prospective cohort study. Cardiovasc Diabetol. 2025 Apr 16;24(1):163. doi: 10.1186/s12933-025-02729-1. Epub 2025 Apr 16. PMID: 40241176; PMCID: PMC12004813.
* Ou H, Wei M, Li X, Xia X. C-reactive protein-triglyceride glucose index in evaluating cardiovascular disease and all-cause mortality incidence among individuals across stages 0-3 of cardiovascular-kidney-metabolic syndrome: a nationwide prospective cohort study. Cardiovasc Diabetol. 2025 Jul 22;24(1):296. doi: 10.1186/s12933-025-02848-9. Epub 2025 Jul 22. PMID: 40696460; PMCID: PMC12281998.
* Ndumele CE, Rodriguez F, Dixon DL, Khan SS, Mukherjee D, Bajaj M, Bangalore S, Bozkurt B, Breathett K, Clarke SL, de Boer IH, Ellison DH, Evangelista LS, Heffron SP, Kazi DS, Kulshreshtha A, Lingvay I, Low Wang CC, Mercado CA, Morton JM, Neeland IJ, Pagidipati N, Powell-Wiley TM, Rangaswami J, Rao G, Reza N, Saeed A, St Peter W, Starks JB, Sterling M, Talbot AW, Tran AH, Tuttle KR, VanWagner LB, Vest AR, Virani SS. 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol. 2026 Jun 9;87(22S):e1889-e2007. doi: 10.1016/j.jacc.2026.03.056. PMID: 42265997; PMCID: PMC13399222.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.